Revenio Group Corporation (REG1V.HE) stock: key figures, P/E, revenue and dividend
Health Care · Health Care Equipment · Finland · ISIN FI0009010912
Revenio Group Corporation financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 103.50 m EUR | 109.70 m EUR |
| Gross profit | 72.90 m EUR | 46.90 m EUR |
| Operating income | 25.05 m EUR | 25.40 m EUR |
| EBIT | 25.33 m EUR | 25.40 m EUR |
| Net income | 18.50 m EUR | 17.40 m EUR |
| Diluted EPS – continuing operations | 0.70 EUR | 0.65 EUR |
Full history since 2000, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Revenio Group Corporation
Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Sensors that are accessories of iCare tonometer for measuring intraocular pressure (IOP); iCare TONOVET Pro, a tonometer designed for use in surgical or emergency settings; and iCare TONOVET Plus tonometer, which is used by veterinarians, ophthalmologists and other personnel to measure intraocular pressure in animal patients. It also provides imaging devices comprising iCare EIDON, a device with confocal retinal imaging; iCare DRSplus, a device for pupil imaging; and iCare COMPASS, which provides fundus perimetry with true-color confocal retinal images. In addition, the company offers iCare ILLUME, a screening software that helps to detect the early signs of diabetic retinopathy, age-related macular degeneration, and glaucoma using artificial intelligence; iCare CLINIC cloud software to store long-term IOP data; and Oculo, an eye care software platform, which combines clinical communication, telehealth, remote patient monitoring and data analytics capabilities. Revenio Group Oyj was incorporated in 2001 and is based in Vantaa, Finland.
More stocks
- Murapol S.A. (MUR.WA)
- Sysgration Ltd (5309.TWO)
- Shanghai Ailu Package Co. Ltd. (301062.SZ)
- Deutsche Rohstoff (DR0.DE)
- Ipd Group Ltd (IPG.AX)
- XMax Inc. (XMAX)
- MCLON JEWELLERY Co.Ltd. (300945.SZ)
- Xinjiang Torch Gas Co Ltd (603080.SS)
- Taiwan Mask Corp (2338.TW)
- Byggmax Group AB (BMAX.ST)
- Angel Oak Financial Strategies Income Term Trust (FINS)
- Pharmicell (005690.KS)
Not investment advice. All data without warranty, price as of 10.11.2026. Details in the risk notice.